Literature DB >> 15592005

The EEG in metabolic encephalopathy and coma.

Peter W Kaplan1.   

Abstract

Excellent early work on stupor and coma can be found (particularly with regard to anoxia) in the work of Fischgold and Mathis (1959) in France, and Pamela Prior in England (1973a). These workers correlated deepening levels of coma with particular EEG patterns, and the suppression of EEG reactivity. Alpha frequency patterns in coma (alpha coma), spindle-like sleep patterns in coma (spindle coma) and "triphasic waves" are among the wide variety of endocrine disorders discussed in case reports and series leading to identification of particular EEG patterns. EEG correlations with prognosis are most reliable with cardiorespiratory arrest (CRA) with its consequent anoxic-ischemic insult. If etiology is known, EEG can often be a reliable predictor of outcome. EEG usually has little specificity with regards to etiology, but some patterns do favor particular diagnoses: for example, triphasic waves (TWs) are frequently seen with hepatic and renal insufficiency in young adults; spindle coma patterns are believed to indicate dysfunction at the brainstem level (Chatrian, 1990). EEG is most useful in differentiating organic from psychiatric conditions, in excluding nonconvulsive status epilepticus (NCSE), and in providing a rough guide as to the degree of cortical and subcortical dysfunction.

Entities:  

Mesh:

Year:  2004        PMID: 15592005

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  48 in total

1.  Reversible encephalopathy induced by cefoperazone: a case report monitored with EEG.

Authors:  Stefano Pro; F Randi; P Pulitano; E Vicenzini; O Mecarelli
Journal:  Neurol Sci       Date:  2010-10-07       Impact factor: 3.307

Review 2.  The neurology of enteric disease.

Authors:  A J Wills; D S N A Pengiran Tengah; G K T Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

Review 3.  Electroencephalography of encephalopathy in patients with endocrine and metabolic disorders.

Authors:  Roland Faigle; Raoul Sutter; Peter W Kaplan
Journal:  J Clin Neurophysiol       Date:  2013-10       Impact factor: 2.177

Review 4.  The intensive care delirium research agenda: a multinational, interprofessional perspective.

Authors:  Pratik P Pandharipande; E Wesley Ely; Rakesh C Arora; Michele C Balas; Malaz A Boustani; Gabriel Heras La Calle; Colm Cunningham; John W Devlin; Julius Elefante; Jin H Han; Alasdair M MacLullich; José R Maldonado; Alessandro Morandi; Dale M Needham; Valerie J Page; Louise Rose; Jorge I F Salluh; Tarek Sharshar; Yahya Shehabi; Yoanna Skrobik; Arjen J C Slooter; Heidi A B Smith
Journal:  Intensive Care Med       Date:  2017-06-13       Impact factor: 17.440

Review 5.  Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

Authors:  Lise L Gluud; Rebecca Jeyaraj; Marsha Y Morgan
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 6.  Sleep in disorders of consciousness.

Authors:  Victor Cologan; Manvel Schabus; Didier Ledoux; Gustave Moonen; Pierre Maquet; Steven Laureys
Journal:  Sleep Med Rev       Date:  2009-06-12       Impact factor: 11.609

7.  Sleep deprivation in critical illness: its role in physical and psychological recovery.

Authors:  Biren B Kamdar; Dale M Needham; Nancy A Collop
Journal:  J Intensive Care Med       Date:  2011-01-10       Impact factor: 3.510

Review 8.  Introduction to interpretation of the EEG in intensive care.

Authors:  L Sewell; A Abbas; N Kane
Journal:  BJA Educ       Date:  2018-12-17

9.  Detecting abnormal electroencephalograms using deep convolutional networks.

Authors:  K G van Leeuwen; H Sun; M Tabaeizadeh; A F Struck; M J A M van Putten; M B Westover
Journal:  Clin Neurophysiol       Date:  2018-11-17       Impact factor: 3.708

10.  Electroencephalography and delirium in the postoperative period.

Authors:  B J A Palanca; T S Wildes; Y S Ju; S Ching; M S Avidan
Journal:  Br J Anaesth       Date:  2017-08-01       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.